Talk:Lipodystrophy
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Lipodystrophy.
|
It is requested that a photograph be included in this article to improve its quality.
The external tool WordPress Openverse may be able to locate suitable images on Flickr and other web sites. |
Hi
editHi, in the "Antiretroviral drugs" section, I would like to remove the statement "(mainly the protease inhibitors)" as this is too generic of a "warning". Recent studies by the AIDS Clinical Trials Group (ACTG: http://www.aactg.org/ -- http://aactg.s-3.com/) [article: http://www.aidsmap.com/en/news/D412C57E-5683-415D-B807-04E69DE1AABF.asp] showed that regimens that contain efavirenz, though simple and generally well tolerated, actually appear to INCREASE risk of lipodystrophy, not decrease. Indeed, in the same study, a boosted protease inhibitor regimen (lopinavir/ritonavir; Kaletra) was shown to cause less lipo when partnered with any nucleoside combination. As a result, I believe the field still contains way too many unknowns to make such a broad statement. If anyone disagrees, or can provide specific citation for this statement then let me know. THANKS! ZacWolf 17:28, 30 May 2007 (UTC)
source
editSystematic review
editdoi:10.1210/jc.2016-2271 - suggests a diagnostic and treatment protocol based on review of >1000 patients. JFW | T@lk 11:13, 18 December 2016 (UTC)
Insulin lipodystrophy source? Suggestion
editThis might be a good source to use for the insulin-induced lipodystrophy section; could I get feedback on whether it is a good-enough quality source and if it would make sense in that section? I'm new to sourcing on Wikipedia and I'm not sure whether this type of source is what is desired. [2] Myoglobin (talk) 01:27, 29 October 2017 (UTC)